5Maus M K H, Grimminger P P, Mack P C, et al.KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies[J].Lung Cancer (Amsterdam, Netherlands ), 2014, 83 (2) : 163-167.
6Kuiper J L, Heideman D A M, Thunnissen E, et al.Incidence of T790M mutation in ( sequential ) rebiopsies in EGFR-mutated NSCLC-patients[J].Lung Cancer ( Amsterdam, Netherlands ), 2014, 85 ( 1 ) : 19-24.
7Antonicelli A, Cafarotti S, Indini A, et al.EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation[J].International Journal of Medical Sciences, 2013, 10 ( 3 ) : 320-330.